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Objective: Elastic ﬁber formation is disrupted with age and by health conditions including aneurysms
and atherosclerosis. Despite considerable progress in the understanding of elastogenesis using the planar
culture system and genetically modiﬁed animals, it remains difﬁcult to restore elastic ﬁbers in diseased
vessels. To further study the molecular mechanisms, in vitro three-dimensional vascular constructs need
to be established. We previously fabricated vascular smooth muscle cells (SMCs) into three-dimensional
cellular multilayers (3DCMs) using a hierarchical cell manipulation technique, in which cells were coated
with ﬁbronectin-gelatin nanoﬁlms to provide adhesive nano-scaffolds. Since ﬁbronectin is known to
assemble and activate elastic ﬁber-related molecules, we further optimized culture conditions.
Methods and results: Elastica stain, immunoﬂuorescence, and electron microscopic analysis demon-
strated that 3DCMs, which consisted of seven layers of neonatal rat aortic SMCs cultured in 1% fetal
bovine serum (FBS) in Dulbecco’s modiﬁed Eagle’s medium, exhibited layered elastic ﬁbers within seven
days of being in a static culture condition. In contrast, the application of adult SMCs, 10% FBS, ε-poly(-
lysine) as an alternative adhesive for ﬁbronectin, or four-layered SMCs, failed to generate layered elastic
ﬁber formation. Radioimmunoassay using [3H]valine further conﬁrmed the greater amount of cross-
linked elastic ﬁbers in 3DCMs than in monolayered SMCs. Layered elastic ﬁber formation in 3DCMs
was inhibited by the lysyl oxidase inhibitor b-aminopropionitrile, or prostaglandin E2. Furthermore,
inﬁltration of THP-1-derived macrophages decreased the surrounding elastic ﬁber formation in 3DCMs.
Conclusion: 3DCMs may offer a new experimental vascular model to explore pharmacological thera-
peutic strategies for disordered elastic ﬁber homeostasis.
 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Arterial walls have a highly organized layer structure that con-
sists of various cells and extracellular matrix (ECM) components. In
particular, the vascular media is composed of a dense population of
concentrically organized smooth muscle cells (SMCs) and elastic
ﬁbers, and plays a pivotal role in maintaining sufﬁcient blood
pressure, even during variations in hemodynamic stress. In physi-
ological conditions, SMCs synthesize elastin and other speciﬁc
molecules, which are incorporated into elastic ﬁbers and arranged
into concentric rings of elastic lamellae around the arterial media
[1]. In contrast, arterial compliance and distensibility are impaired
in the presence of cardiovascular disease and risk factors such as
aortic aneurysm, atherosclerosis, ischemic heart disease, aging,
hypertension, cigarette smoking, and diabetes [2]. Hence, impaired
elastic properties are associated with arterial dysfunction and
pathophysiology [2,3].
Changes in arterial elastic properties are the result of alterations
in the intrinsic structural properties of the artery, including the
fracturing and thinning of elastic ﬁbers. Current approaches to
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examining the elastogenesis and degradation of elastic ﬁbers rely
heavily on the use of the planar culture of vascular SMCs and
genetically modiﬁed animals. These approaches have been instru-
mental in numerous discoveries and have been modiﬁed to create
very elegant experimental designs [1,4e7]. Currently, however, no
pharmacological strategy to promote elastogenesis and prevent the
degradation of elastic ﬁber formation is available, and the molec-
ular mechanisms of the regulation of elastic ﬁber formation remain
to be studied. The two-dimensional (2D) monolayer culture system
is a useful method for isolating speciﬁc factors and their effects on
speciﬁc cell types [5e7], but it lacks the native-like layered struc-
ture of elastic ﬁbers. Therefore, changes in the spatial arrangement
of elastic ﬁbers induced by various stimuli and the inﬁltration of
immune cells cannot be observed. In-vivo analysis, on the other
hand, often fails to discriminate among the various and complex
factors. In this context, in vitro reconstruction vessel models
overcoming these limitations are considered potential platforms of
vascular biology that can provide further insights into the spatio-
temporal molecular mechanisms of elastic ﬁber formation.
We previously developed a novel three-dimensional (3D) cell
construction method [8] and created 3D-layered blood vessel
constructs consisting of human umbilical arterial SMCs and human
umbilical vascular endothelial cells [9]. To develop the 3D-cellular
multilayers (3DCMs), we fabricated nanometer-sized cell adhesives
like ECM scaffolds onto the surface of a cell membrane, which en-
ables another cellular layer to adhere to the coated cell surface. We
employed a layer-by-layer (LbL) technique to fabricate ﬁbronectine
gelatin nanoﬁlms onto living cell membranes, because the LbL
technique produces nanometer-sized polymer ﬁlms with a
controllable nanometer thickness through the alternate immersion
into interactive polymer solutions. We found that approximately
6 nm of ﬁbronectin-based nanoﬁlms were suitable for developing
stable adhesive scaffolds and for creating allogeneic or xenogeneic
multiple cell layers.
In addition to the cell adhesion effect, ﬁbronectin has been
known to orchestrate the assembly of the ECM [10e15]. In partic-
ular, recent reports suggest that ﬁbronectin ﬁber assembles peri-
cellularly into ﬁbrillin microﬁbrils that have a complex structural
organization and are widespread in elastic tissues [10,16].
Furthermore, ﬁbronectin binds to lysyl oxidase (LOX), a cross-
linking enzyme for elastic ﬁbers, and acts as a scaffold for enzy-
matically active 30 kDa LOX [14]. Using scanning electron micro-
scopy and transmission electron microscopy, we observed that
ﬁbronectin formed extracellular ﬁbrils in the abovementioned
3DCMs within 24 h cultures [9], suggesting that ﬁbronectin-coated
SMCs have the potential to produce elastic ﬁber assemblies. In this
context, we aimed to create the ﬁrst scaffold-free 3D cellular
multilayers (3DCMs) that are speciﬁcally designed for investigating
the spatial regulation of vascular elastic ﬁbers by employing this
LbL assembly technique. The present study demonstrates that the
optimized culture conditions provided layered elastic ﬁber forma-
tion in the 3DCMs consisting of neonatal rat SMCs within seven
days of static culture conditions. In the 3DCMs, it was observed in
the vertical view that macrophage inﬁltration or prostaglandin E2
(PGE2) changed the spatial arrangement of elastic ﬁbers.
2. Materials and methods
Expanded materials and methods are described in
Supplemental data.
2.1. Animals
Neonate (day 1) and adult Wistar rats (4e5months old) were
obtained from Japan SLC, Inc. (Shizuoka, Japan). All animal studies
were approved by the institutional animal care and use committees
of Yokohama City University.
2.2. Cell culture
Vascular SMCs in primary culture were obtained from the aorta
of rat neonates (day 1) as previously described [17e19]. Brieﬂy, the
minced tissues were digested with a collagenase-dispase enzyme
mixture at 37 C for 20 min. The cell suspensions were then
centrifuged, and the medium was changed to a collagenase II
enzyme mixture. After 12 min of incubation at 37 C, cell suspen-
sions were plated on 35 mm poly-L-lysine-coated dishes The
growth medium contained Dulbecco’s modiﬁed Eagle medium
(DMEM)with 10% fetal bovine serum (FBS),100 U/ml penicillin, and
100 mg/ml streptomycin (Invitrogen, Carlsbad, CA). Human adult
aortic SMCswere obtained from Lonza (Walkersville, MD, USA). The
conﬂuent SMCs were used at passages 5e7. THP-1 cells were ob-
tained from the Health Science Research Resources Bank (Osaka,
Japan) and were maintained in RPMI 1640 medium (Wako, Osaka,
Japan) supplemented with 10% FBS. All cells were cultured in a
moist tissue culture incubator at 37 C in 5% CO2-95% ambient
mixed air.
2.3. Construction of 3DCMs
Construction of 3DCMs was performed as previously described
[8]. Brieﬂy, a cell disk LF (Sumitomo Bakelite, Tochigi, Japan) was
rinsed with 50 mM TriseHCl buffer solution (pH 7.4) for 15 min and
coated with ﬁbronectin (0.2 mg/ml) for 30 min at 37 C. SMCs were
cultured on the cell disk (11 104 cells/cm2) and incubated for 12 h
in 10% FBS/DMEM. The monolayered SMCs were then immersed
alternatively in a solution of ﬁbronectin (0.2 mg/ml) and gelatin
(0.2 mg/ml). After nine steps of LbL assembly with ﬁbronectin and
gelatin, a second cell layer was seeded on the ﬁrst cell layer
(11104 cells/cm2) and incubated for 6e12 h at 37 C. The cycles of
LbL nanoﬁlm assembly and subsequent cell seeding were repeated
six times in four days to construct seven-layered 3DCMs. During the
ﬁrst four days, the mediumwas refreshed daily. Twelve hours after
the seeding of the last layer, the culture media was changed to
DMEM or DMEM/F-12 (Gibco, Carlsbad, CA) containing 1% FBS or
10% FBS. The 3DCMs were incubated for an additional 48 h and
either ﬁxed in buffered 10% formalin or harvested in TRIzol (Invi-
trogen, Carlsbad, CA). The time-course of the 3DCM experiments is
shown in Supplemental Fig. 1A. Stimulation by b-amino-
proprionitrile (BAPN) or PGE2 (1 mM) was performed simulta-
neously with the medium change on day 5. For macrophage
inﬁltration assay, seven-layered 3DCMs at day 5 were put on a 24-
well plate and applied with 500 ml of RPMI 1640 medium con-
taining THP-1 cells (2.0  105 cells) with or without phorbol 12-
myristate 13-acetate (PMA, 0.1 mM). The 3DCMs were incubated
for 1 h at 37 C. Next, unattached THP-1 cells werewashed out with
PBS and 3DCMs were incubated in 1% FBS/DMEM for 72 h until
ﬁxation. Control monolayered neonatal rat aortic SMCs (2D-SMCs)
were plated on day 4 in the same density as a single layer in 3DCMs
(11  104 cells/cm2), and were incubated for 48 h. Four-layered
3DCMs were constructed from day 3 following the same time-
course. The proportional increase in the thickness of 3DCMs with
the number of seeding events was shown in Supplemental Fig. 1B.
To conﬁrm the effect of ﬁbronectin nanoﬁlms, ε-poly(lysine)
(0.2 mg/ml) was used as an alternative adhesive polymer.
2.4. Quantitative measurement of insoluble elastin
Newly synthesized insoluble elastinwasmeasured as previously
described [20,21]. Brieﬂy, after the seven-layered 3DCMs and 2D-
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SMCs were constructed for four days and one day, respectively, as
mentioned above, they were incubated in 2 ml of 1% FBS/DMEM in
the presence of 5 mCi [3H]valine (ART 0466, American Radiolabeled
Chemicals, Inc., St. Louis, MO) for an additional three days. One day
after the monolayered SMCs were plated, the cells were harvested
in 0.1 M acetic acid on ice. After centrifugation, the pellets were
boiled in 0.1 N NaOH for 1 h. The NaOH-insoluble fractions were
collected by centrifugation and were boiled in 5.7 N HCl for 1 h. The
samples mixed with scintillation ﬂuid were measured for radio-
activity using a scintillation counter (Beckman Coulter).
2.5. Statistical analyses
Data are presented as the mean  standard error of the mean
(SEM) of independent experiments. Data were analyzed by the
unpaired Student’s t-test or one-way analysis of variance (ANOVA)
followed by NewmaneKeuls multiple comparison test. p < 0.05
was considered signiﬁcant.
3. Results
3.1. 3DCMs exhibited layered elastic ﬁber formation
Most of the elastic ﬁber proteins are expressed in the second
half of development and increase throughout the early postnatal
period [22]. This is followed by a decrease in expression to low
levels that persist through adulthood [23]. Consistent with this
in vivo evidence, it has been suggested that neonatal rat SMCs
produce a greater amount of elastin and elastic ﬁbers compared to
adult rat SMCs [24,25]. We conﬁrmed that mRNA expression levels
of elastic ﬁbererelated genes, such as tropoelastin, ﬁbrilin-1, ﬁbu-
lin-4, ﬁbulin-5, LOX, and LOX-like 1, are signiﬁcantly greater in the
neonatal rat aorta (1 day old) than in the adult rat aorta
(Supplemental Fig. 2).
On the basis of these data, we used neonatal rat SMCs to fabri-
cate 3DCMs as in vitro vascular constructs. First, we cultured
3DCMs with four different culture media, including DMEM and
DMEM F-12, because DMEM F-12 includes proline, one of the major
amino acids that constitutes elastin protein, and copper, which
enhances LOX activity [26]. Contrary to expectations, nucleus
counting using HE stain revealed that viability was better in the
3DCMs cultured in DMEM (Fig. 1AeB, Supplemental Fig. 3) than in
DMEM F-12 containing either 10% or 1% FBS (Fig. 1CeD). Next, we
compared elastic ﬁber formation using Elastica van Gieson (EVG)
stain in 3DCMs cultured in DMEM containing 10% or 1% FBS. We
found that 3DCMs cultured in 1% FBS/DMEM exhibited layered
elastic ﬁber formation (Fig. 1E), although the elastic ﬁber formation
did not reach that observed in adult rat aorta (Fig. 1F) The 3DCMs
culture in 10% FBS/DMEM exhibited a certain amount of positive
stain of elastic ﬁbers, but no layered elastic ﬁber formation was
clearly detected (Fig. 1G). In the 3DCMs culture in 1% FBS/DMEM,
co-immunoﬂuorescence for ﬁbrillin-1 and a-smooth muscle actin
(aSMA) demonstrated a ﬁber meshwork of ﬁbrillin-1 on the SMC
surface (Fig. 1H). Electron microscopic analysis also conﬁrmed the
presence of elastic laminae between SMC layers (Fig. 1I).
To investigate whether the use of ﬁbronectin nanoﬁlms is
required for elastic ﬁber formation in the 3DCMs, we applied
ε-poly(lysine), a synthesized polymer that electrically binds to
gelatin, as an alternative to ﬁbronectin in the 3DCMs. We found
that ε-poly(lysine) did not provide layered elastic ﬁber formation
(Supplemental Fig. 4A). As expected, the 3DCMs composed of
adult human aortic SMCs or adult rat aortic SMCs also did not
exhibit elastic ﬁber formation (Supplemental Fig. 4BeC).
Furthermore, we compared elastic ﬁber formation between the
3DCMs and another 3D model, i.e., the spheroid culture system.
We constructed spheroids of neonatal rat SMCs with the same
culture conditions of 3DCM construction (Supplemental Fig. 5A)
and found that a few elastic laminae were formed in the outer
shell of rat SMC spheroids, but not in the porous core
(Supplemental Fig. 5BeC).
To quantify the amount of mature (i.e., cross-linked) elastic ﬁ-
bers in 3DCMs, we metabolically labeled newly synthesized elastin
with [3H]valine, and measured the incorporation of [3H]valine in
the NaOH-insoluble fraction of these cells, which reﬂects the
amount of newly synthesized mature elastic ﬁbers [27]. As shown
in Fig. 1J, in 3DCMs cultured with 1% FBS/DMEM, we detected a
signiﬁcant increase in the incorporation of [3H]valine into the
insoluble fraction compared to 2D-SMCs cultured in the same
culture medium. Interestingly, seven-layered 3DCMs produced a
larger amount of cross-linked elastic ﬁbers than four-layered
3DCMs even if the values were compared in the same amount of
protein (Fig. 1J and Supplemental Fig. 4D). These data suggest that
seven-layered 3DCMs consisting of ﬁbronectin coating neonatal rat
aortic SMCs cultured in 1% FBS/DMEM produced layered elastic
ﬁbers in vitro.
3.2. Expression of elastic ﬁber-related genes in 3DCMs
Elastic ﬁbers are complex structures that contain elastin as well
as microﬁbrils and ﬁbulins [1]. Elastin is the major component of
mature elastic ﬁbers, and microﬁbrils, such as ﬁbrillin-1 and
ﬁbrillin-2, are known to facilitate elastin assembly and provide
overall structure to the growing elastic ﬁber [1]. Tropoelastin’s
lysine residues are, in turn, modiﬁed to form covalent cross-links
between and within elastin molecules by LOX, resulting in the
functional form of elastic ﬁbers [1,26]. The deposition of ﬁbulin-5
on microﬁbrils also promotes the coacervation and alignment of
tropoelastins on microﬁbrils, and facilitates the cross-linking of
tropoelastin by tethering LOXelike 1, 2, and 4 enzymes [20].
Fibulin-4 interacts with LOX and recruits LOX to elastin monomers
as well [28].
We examined the mRNA expression levels of these genes in
the 3DCMs cultured in DMEM containing 1% or 10% FBS and 2D-
SMCs. The expression levels of tropoelastin and ﬁbrillin-2 mRNAs
were greater in the 3DCMs cultured in 1% FBS/DMEM than in 10%
FBS/DMEM (Fig. 2AeB). The expression levels of other genes,
including ﬁbrillin-1, ﬁbulin-4, ﬁbulin-5, LOX, and LOX-like 1, were
similar among different serum concentrations (Fig. 2CeG). Similar
serum withdrawal effects on tropoelastin and ﬁbrillin-2 mRNA
were also observed in 2D-SMCs (Supplemental Fig. 6AeB). In
3DCMs cultured in 1% FBS/DMEM, abundant protein expressions
of tropoelastin and LOX were also observed (Fig. 2HeI). However,
there was no difference in the expression of elastic ﬁber-related
genes between 2D-SMCs and 3DCMs (Fig. 2AeG, JeK). These data
Fig. 1. 3DCMs cultured in 1% FBS/DMEM exhibited layered elastic ﬁbers. (AeB) Hematoxylin eosin (HE) stain of 3DCMs cultured in DMEM containing either 1% (A) or 10% FBS (B). HE
stain of 3DCMs cultured in DMEM F-12 containing either 1% (C) or 10% FBS (D). (E) Elastica van Gieson (EVG) stain of 3DCMs cultured in 1% FBS/DMEM. Scale bars: 10 mm. (F) EVG
stain of rat adult aorta. Scale bar: 50 mm. (G) EVG stain of 3DCMs cultured in 10% FBS/DMEM. Scale bar: 10 mm. (H) Confocal images of the ﬁbrillin-1 and aSMA immunofluorescence
in the 3DCMs cultured in 1% FBS/DMEM. red: ﬁbrillin-1. Green: aSMA. Scale bar: 50 mm. (I) Electron microscopic image of 3DCMs. White arrow indicates elastic ﬁbers. N: nucleus.
Scale bar: 2.0 mm. (J) Radioimmunoassay of elastogenesis in 2D-SMCs, four-layered 3DCMs, and seven-layered 3DCMs cultured in 1% FBS/DMEM. n ¼ 4e8. *p < 0.05; ***p < 0.001;
NS: not signiﬁcant.
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suggest that the 3D-SMC arrangement per se did not affect elastic
ﬁbererelated gene expressions, and that the serum withdrawal
likely induced an enhancement of the expression of tropoelastin
and ﬁbrillin-2, resulting in elastic ﬁber formation in the 3DCMs
cultured in 1% FBS/DMEM.
3.3. Characterization of the SMC phenotype in 3DCMs
In contrast to the highly differentiated SMCs in mature adult
organs, SMCs readily undergo phenotypic changes after isolation
and subsequent conventional planar culture [29]. We examined
Fig. 2. Expressions of elastic ﬁbererelated genes in 3DCMs. (AeG) Expressions of tropoelastin (A), ﬁbrillin-2 (B), ﬁbrillin-1 (C), ﬁbulin-4 (D), ﬁbulin-5 (E), LOX (F), and LOXelike 1
(G) mRNAwere compared between 2D-SMCs (2D) cultured in 1% FBS/DMEM and 3DCMs cultured either in 1% FBS/DMEM or 10% FBS/DMEM. n ¼ 6e8. *p < 0.05. NS: not signiﬁcant.
(HeI) Immunohistochemistry for tropoelastin (H) and LOX (I). Brown color indicates positive staining. top panels: 3DCMs. Scale bars: 10 mm lower panels: rat adult aorta. Scale bars:
50 mm. (JeK) Immunoblot analysis for elastin (J), and LOX (K) in 2D-SMCs and 3DCMs.
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Fig. 3. Characterization of SMC phenotype in 3DCMs. (AeH) Messenger RNA expressions of differentiation SMC markers, SM1 (A), SM2 (B), aSMA (C), SM22a (D), desmin (E),
calponin (F), h-caldesmon (G), myocardin (H), and a dedifferentiation SMC marker, SMemb (I) in 2D-SMCs, 3DCMs, and SMC spheroids. n ¼ 4e8. (J) Immunoblot analysis for SM1 in
2D-SMCs and 3DCMs. Rat adult aorta was used as positive control. (K) Quantiﬁcation of (J). n ¼ 10. (L) Immunoblot analysis for SMemb in 2D-SMCs and 3DCMs. (M) Quantiﬁcation of
(L). n ¼ 10. *, p < 0.05; **, p < 0.01; ***, p < 0.001. NS: not signiﬁcant. Immunohistochemistry for SM1 (N) and SM2 (O). Brown color indicates positive staining. top panels: 3DCMs.
Scale bars: 10 mm lower panels: rat adult aorta. Scale bars: 50 mm.
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Fig. 4. Pharmacological manipulation of elastic ﬁber formation in 3DCMs. (AeB) EVG stain of 3DCMs. CTRL (A), and BAPN (1 mM) stimulation (B). Scale bars: 10 mm. (C) Quanti-
ﬁcation of the density of elastic ﬁbers in (A) and (B). n ¼ 5. (DeE) Macroscopic images of 3DCMs treated with or without PGE2 (1 mM) (PGE2 and CTRL, respectively). Scale bars:
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SMC differentiation in this culture system in comparison to 2D-
SMCs and SMC spheroids by monitoring the expression of various
SMC markers.
It has been reported that the expression levels of differentiation
SMC markers, such as SM1, SM2, aSMA, SM22a, and desmin, were
highly expressed in the medial layer of SMCs but reduced in human
subendotherial intima of atherosclerotic lesions [30e33] and hu-
man and rabbit aortic aneurysmal lesions [34,35]. Differentiation
SMC markers such as the high molecular weight isoform of cal-
desmon (h-caldesmon) and calcium-binding protein calponin are
also suggested to be downregulated in human atheromatous intima
[31,32]. The serum response factor coactivator gene myocardin is
required for the expression of many SMC differentiation marker
genes and for the initial differentiation of SMC [29]. SMemb is
known to be a dedifferentiation SMC marker that is abundantly
expressed in human fetal arteries and immature adult cells that are
present in vascular injury-induced intima [29]. Expression analysis
of mRNAs demonstrated that most differentiation markers were
similarly expressed between 2D-SMCs and 3DCMs (Fig. 3AeH).
Although the expression levels of SM1 mRNA were higher in
3DCMs than in 2D-SMCs, the SM1 protein expression did not differ
between these two culture systems (Fig. 3JeK). Among the SMC
phenotypic markers examined, only SMemb was reduced in the
3DCMs compared to the 2D-SMCs in both mRNA and protein
(Fig. 3I, L,M).
We also examined the SMC phenotypes of SMC spheroids in
comparison with 3DCMs. mRNA expressions of all differentiation
SMC markers examined in the whole spheroids were lower than in
3DCMs and even 2D-SMCs (Fig. 3AeH). The expression level of
SMemb mRNA in the spheroids was similar to 2D-SMCs and
3DCMs.
Immunohistochemistry showed that SM1 and SM2 proteins
were homogenously expressed in 3DCMs (Fig. 3N,O). In SMC
spheroids, SM1 and SM2 were expressed mainly in the outer shell,
while the dedifferentiation marker SMemb was expressed in the
porous core (Supplemental Fig. 5D,F).
These data suggested that the 3DCMs exhibited similar SMC
phenotypes to 2D-SMCs, although a differentiated phenotype was
maintained compared to the other types of 3D culture, i.e., SMC
spheroids.
3.4. Pharmacological manipulation of elastic ﬁber formation in
3DCMs
To examine the molecular mechanisms of the elastogenesis and
degradation of elastic ﬁbers, and to explore new therapeutic stra-
tegies against elastic ﬁber formation disorders, pharmacological
manipulations of 3DCMs are essential. In this context, we examined
whether elastic ﬁber formation in 3DCMs was regulated by the
drug that inhibits the cross-linking of elastin monomers to form
insoluble elastic ﬁbers [1,26]. When BAPN, an inhibitor of LOX, was
applied to 3DCMs for the last two days of culture, the elastic ﬁber
formation was signiﬁcantly inhibited (Fig. 4AeC).
The biosynthesis of PGE2 is increased in human atherosclerotic
plaques [36] and has been implicated in atherosclerotic plaque
rupture [37]. PGE2 is abundantly produced in aortic aneurysmal
lesions and it decreases elastic ﬁber formation [38,39]. Therefore,
we stimulated the 3DCMs with PGE2 and found that PGE2 stimu-
lation induced a partial disruption of the layer structure of SMCs
(Fig. 4DeE) and decreased elastic ﬁber formation (Fig. 4FeK). These
data suggest the potential use of 3DCMs for pharmacological
manipulation of elastic ﬁber formation.
3.5. Inﬁltration of macrophages decreased elastic ﬁbers in 3DCMs
The inﬁltration of macrophages into the vascular wall is a critical
step in the progression of atherosclerosis and aortic aneurysm, and
macrophages are the main source of PGE2. We applied THP-1
(human monocyte cell line) to the 3DCMs with or without PMA,
which induces the differentiation of THP-1, into activated macro-
phages. Non-activated THP-1 (CTRL) did not inﬁltrate 3DCMs or
affect the SMC layer structure or elastic ﬁber formation (Fig. 5A, C,
E, and G). On the other hand, activated macrophages inﬁltrated the
3DCMs (Fig. 5D, H) and decreased the surrounding elastic ﬁbers and
disrupted the layer structure of SMCs (Fig. 5)B, F, H, and I.
4. Discussion
Despite numerous discoveries related to the molecular mecha-
nisms of elastic ﬁber formation, circulatory diseases associated
with elastic ﬁber disorder, such as aneurysms and atherosclerosis,
remain the predominant cause of mortality and morbidity in the
developed world [40]. No pharmacological strategy to restore the
elastic ﬁber assembly in diseased vessels or to inhibit the pro-
gression of elastin-related diseases is currently available. To obtain
further mechanistic insights into elastic ﬁber formation, in the
current study, we sought to create a new experimental vascular
model designed speciﬁcally for vascular elastic ﬁber research. We
optimized culture conditions and found that 3DCMs consisting of
ﬁbronectin-gelatin-coated neonatal rat aortic SMCs cultured in 1%
FBS/DMEM exhibited layered elastic ﬁber formation within seven
days, and that the amount of newly synthesized insoluble elastic
ﬁbers was signiﬁcantly greater in 3DCMs than in 2D-SMCs cultured
in the same medium.
Recent advances in tissue-engineered blood vessels that are free
of synthetic scaffolds enabled the assembly of multiple layers of
SMCs and the production of elastic ﬁber deposition in vitro [41].
These techniques provide excellent mechanical properties as
implantable vascular constructs but require an excessively long
culturing time and/or an in vivo bioreactor, neither of which are
practical for ex vivo experimental vascular models. In this study,
ﬁbronectin nanoﬁlms prepared on the surface of SMCs, which has
not been used in other tissue-engineered blood vessels, were
adopted in 3DCMs for hierarchical cell manipulation and rapid in-
duction of elastic ﬁber formation. The recent proteomics approach
enabled comprehensive molecular interactions in elastic ﬁber as-
sembly and revealed that ﬁbronectin and microﬁbril ﬁbrillin play a
central role [42]. Kinsey et al. and Sabatier et al. demonstrated that,
in addition to expression, ﬁbronectin assembly is a prerequisite for
ﬁbrillin assembly [10,16]. It is noted that ﬁbronectin assembly and
subsequent ﬁbrillin assembly in vitro were observed within a
couple of days in the static culture condition [10,16]. Other lines of
in vitro studies demonstrated that ﬁbronectin is critical for the
deposition of latent transforming growth factor b-binding protein-
1 (LTBP-1), which is associated with microﬁbrils [11], and that
ﬁbronectin assembly promotes LOX activation [14]. Our previous
report demonstrated that pericellular ﬁbronectin ﬁbers were
observed in 3DCMs within 24 h [9]. In addition, our results
demonstrated that the use of ε-poly(lysine) instead of ﬁbronectin
failed to generate elastic ﬁber formation. These data support our
1 mm. (FeG) EVG stain of 3DCMs. (HeI) Immunoﬂuorescent images of ﬁbrillin-1 in 3DCMs red: ﬁbrillin-1. Scale bars: 50 mm. CTRL (D,F,H) and PGE2 stimulation (E,G,I). (J) top panel:
Histograms showing the density of EVG positive area/total area. lower panels: EVG stain of CTRL 3DCMs and PGE2 stimulated 3DCMs. Scale bars: 100 mm. (K) Quantiﬁcation of
density of ﬁbrillin-1 in (H) and (I). n ¼ 11. *p < 0.05.
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concept that the pericellular ﬁbronectin meshwork on SMCs con-
tributes to elastic ﬁber assembly in 3DCMs.
Elastinmolecules play a crucial role in elastic ﬁber formation [1].
It has been reported that elastin is expressed maximally at the G0
and minimally at the G2/M phase during the cell cycle [43,44]. In
accordance with previous reports, serum withdrawal increased
tropoelastin mRNA expression in both 3DCMs and 2D-SMCs. Our
data suggest that serum withdrawaleinduced cell cycle regulation
Fig. 5. Inﬁltration of macrophages decreased elastic ﬁbers in 3DCMs (AeB) Macroscopic images of 3DCMs treated with non-activated THP-1 (CTRL), or activated macrophages
(PMA). Scale bars: 1 mm. (CeD) Immunoﬂuorescent images of ﬁbrillin-1 (red) and CD68 (green) in 3DCMs. (EeF) EVG stain of 3DCMs. (GeH) Immunoﬂuorescent image of ﬁbrillin-1
(red) and CD 68 (green) in 3DCMs. White arrow indicates inﬁltrated macrophage. Scale bars: 50 mm. (I) Quantiﬁcation of the density of ﬁbrillin-1 in (G) and (H). n ¼ 11. *p < 0.05.
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has a favorable effect on elastic ﬁber formation. Fibrillin-2 which
contributes to the initial assembly of elastic ﬁbers as well as
ﬁbrillin-1 was also induced by serum-starved conditions in both
3DCMs and 2D-SMCs. Cell cycle regulation potentially contributes
to the formation of elastic ﬁbers in 3DCMs via the increase in elastin
and ﬁbrillin-2.
In addition to the ﬁbronectin nanoﬁlm and culture media
component, the use of neonatal vascular SMCs may also contribute
to elastic ﬁber formation in 3DCMs, because it has been well
documented that adult vascular SMCs lose the ability to produce
components related to elastic ﬁber assembly, including tropoelastin
and ﬁbrillins [1,22,24]. In our study, 3DCMs using adult human
aortic SMCs did not produce elastic ﬁbers, even if the same ﬁbro-
nectin coating and culture conditions were applied. In addition to
these factors, our data suggest that a certain number of SMC layers
are required for elastic ﬁber formation. Although the exact mech-
anisms of the rapid induction of elastic ﬁbers in 3DCMs are not
known, the multiple factors in 3DCMs, such as the type of SMC, the
ECM coated on the cells, the culture media components, and the
number of SMC layers are considered to allow layered elastic ﬁbers
even in short periods in a static culture condition.
Under physiological conditions, the majority of SMCs in the
medial layer of the artery are considered to be in a differentiated
(contractile) state that is hardly retained in planar cell culture [29].
Unexpectedly, our results suggest that SMC phenotypes in 3DCMs
are similar to those in 2D-SMCs except SMemb expression. Since
the differentiated status in SMCs varies through developmental
stages and under pathological conditions, including atherosclerosis
and vascular injury [45], an understanding of the differentiation
status of SMCs in 3DCMs is important in vascular biology research.
One study limitation is that SMCs in 3DCMs were not fully differ-
entiated and the elasticity seemed signiﬁcantly low compared to
native vascular tissues. Further modiﬁcation of 3DCMs, such as
modulating SMC phenotypes before creating 3D construction by
means of pharmacological stimuli or mechanical stress, is required
in future studies.
In the present study, we demonstrated that elastic ﬁber for-
mation in 3DCMs was disturbed by a LOX inhibitor and PGE2,
suggesting that pharmacological manipulation could be applied in
3DCMs. The relatively small reduction in elastic ﬁber formation by
BAPN may be due to the 2-day administration out of the 7 days of
culture. In conventional in vivo study using systemic drug admin-
istration, drug metabolism profoundly affects it efﬁcacy, and its
indirect effects cannot be discriminated. Although emerging evi-
dence has demonstrated advances in drug delivery systems such as
nanoparticles and antibody-drug conjugates that enable tissue-
speciﬁc targeting strategy, they remain impractical for initial drug
screening [46]. 3DCMs may offer a new strategy to examine the
direct effects of various drugs on vascular elastic ﬁber formation
and phenotypic changes of SMCs.
There have been excellent in vitro systems using 2D culture to
examine molecular mechanisms of elastic ﬁber formation [5e7],
because insoluble mature elastic ﬁbers can be formed in certain
conditions of 2D culture systems. However, elastic ﬁber formation
in a vertical sectional view cannot be observed in 2D culture sys-
tems. In this study, it is suggested that the inﬁltration of macro-
phages and its effects on the spatial arrangement of elastic ﬁbers
can be observed in 3DCMs.
Spheroid culture system has been established as a 3D culture of
SMCs. For example, the spheroids with vascular SMCs retain elec-
trophysiological and contractile properties [47,48]. Paracrine effects
of SMCs on gap junction formation of endothelial cells were also
shown using the spheroids with human vascular cells [49]. To the
best of our knowledge, however, elastic ﬁber formation and the
effect of macrophage inﬁltration on SMCs have not been reported in
SMC spheroids. Our study revealed that, in SMC spheroids, a few
numbers of elastic laminae were formed between the outer shell
and porous core at least under the same culture conditions as
3DCMs. Since a single spheroid has around 100 mm in diameter and
consists of heterogeneous SMC phenotypes (Supplemental Fig. 5), it
seems difﬁcult to construct larger numbers of elastic laminae. On
the other hand, the 3DCMs exhibited multiple layered elastic
laminae spread over an area of at least 5 mm2 (Fig. 4D). Further-
more, it was visible with a low magniﬁcation that macrophage
inﬁltration induced disruption of elastic ﬁber assembly in the
3DCMs. In comparisonwith spheroid culture system, 3DCMswould
be suitable for studies of elastic ﬁber formation in pathophysio-
logical setting.
In conclusion, 3DCMs have the potential to be a new vascular
experimental platform in which the spatial and temporal regula-
tion of vascular elastic ﬁbers can be observed. Since the regulation
of vascular elastic ﬁber formation can be examined in 3DCMs, they
may be useful for exploring pharmacological therapeutic strategies
against disordered elastic ﬁber homeostasis, such as atherosclerotic
vascular disease for which no pharmacological treatment is
currently available.
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